{"chunk_id": "The-Pregnancy-and-Lactation-Labeling-Rule-(PDF---656KB)__chunk_33", "source": "The-Pregnancy-and-Lactation-Labeling-Rule-(PDF---656KB)", "text": "Example:   \n8.2 Lactation- Risk Summary \n Risk Summary \nLimited published literature based on breast milk sampling from \nfive mothers, reports that [drugname] is present in human milk, \nwhich resulted in infant doses of 0.16% to 0.7% of the maternal \nweight-adjusted dosage and a milk/plasma ratio ranging between \n1.1 and 2.7. There are no reports of adverse effects on the breastfed \ninfant and no effects on milk production. However, long-term \nneurodevelopmental effects on infants from stimula"}